Evidence
BLimited human data
a small molecule
L-Carnitine is a quaternary ammonium compound synthesized from lysine and methionine in the liver, kidneys, and brain. It is an endogenous conditionally essential nutrient — the body produces it but dietary intake (primarily from red meat and dairy) meaningfully contributes to tissue pools. It is NOT classified as a peptide, protein, or amino acid in the conventional sense, though it is derived from amino acid precursors. Its inclusion in this reference reflects its widespread community use alongside peptides in longevity, athletic, and anti-aging protocols. Chemical formula: C₇H₁₅NO₃. MW 161.20 Da. Zwitterionic at physiological pH.
The Four Forms
L-Carnitine (LCNC): the base form; fat transport into mitochondria; dietary/supplement standard. Acetyl-L-Carnitine (ALCAR): acetylated form; crosses the blood-brain barrier; the only form with cognitive and neuroprotective effects; acetyl group serves as acetylcholine precursor; most important form for CNS applications. L-Carnitine L-Tartrate (LCLT): tartrate salt; fastest absorption; specifically studied for exercise recovery and androgen receptor upregulation; the athlete-specific form. Propionyl-L-Carnitine (PLCAR): propionyl modification; specifically improves peripheral vascular function via nitric oxide; the circulation-specific form. Using the wrong form for the desired outcome is the most common clinical error.
The Central Function
Carnitine's primary function: transporting long-chain fatty acids (LCFA) across the inner mitochondrial membrane via the carnitine-acylcarnitine translocase system. Without carnitine, LCFA cannot enter the mitochondrial matrix for beta-oxidation (fat burning). Carnitine thus serves as the gatekeeper for mitochondrial fat metabolism. Secondary functions: buffering excess acyl groups (preventing acyl-CoA accumulation that inhibits energy metabolism); ALCAR specifically donates acetyl groups for acetylcholine synthesis and cardiolipin synthesis in mitochondrial membranes.
FDA Status
L-Carnitine injection (Carnitor) is FDA-approved for carnitine deficiency in patients on hemodialysis — one of the few supplement-adjacent compounds with a genuine FDA approval. Oral L-carnitine is GRAS (generally recognized as safe). ALCAR, LCLT, and PLCAR are dietary supplements in the US — not FDA-approved drugs but legal for sale. No WADA prohibition.
The TMAO Concern
Gut bacteria convert dietary L-carnitine → TMA (trimethylamine) → liver converts TMA → TMAO (trimethylamine N-oxide) via FMO3 enzyme. Koeth et al. 2013 (Nature Medicine) documented the carnitine → TMAO → atherosclerosis pathway. Mendelian randomization (BMC Medicine 2022, Zhao et al.): genetically predicted higher L-carnitine associated with OR 1.07 for coronary artery disease — a small but real signal. ALCAR has lower TMAO impact than plain L-carnitine due to faster absorption reducing gut bacterial exposure. The TMAO concern modifies the risk-benefit assessment for healthy individuals with normal carnitine status.
The Evidence Summary
The evidence base is large but form-specific: ALCAR for neuropathy (Grade B — meta-analyses); ALCAR for cognitive aging/MCI (Grade B — 21-study meta-analysis); LCLT for exercise recovery and androgen receptor upregulation (Grade B — Volek 2002); PLCAR for peripheral artery disease walking distance improvement (Grade B — meta-analysis, ~90m gain); L-Carnitine for male infertility (Grade B — sperm motility); L-Carnitine post-MI cardiac outcomes (Grade B — DiNicolantonio 2013, 27 RCTs); L-Carnitine in hemodialysis (Grade A — FDA approved). Fat loss in healthy adults: Grade C — modest, inconsistent, primarily relevant in deficient populations (CKD, vegans, elderly).